Search results
Enter the tumour characteristics and click on “calculate” to determine the annual recurrence risk and disease-free survival. The model can be used to plan an individual surveillance strategy based on prognostic factors.
Find out how the My CancerIQ cervical cancer risk assessment works and receive your personalized action plan report so you can manage your risk factors and reduce your risk. What’s your risk of cervical cancer?
This website is designed to help you understand cervical cancer screening and what the next steps are after an abnormal result. The Personalized Risk Assessment Tool will walk you through the steps that a doctor or healthcare provider may use when deciding management after an abnormal result.
Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cer-vical cytology alone.
Cervical Cancer Recurrence Risk Calculator. The risk calculator model is applicable for patients with early-stage cervical cancer (T1a–T2b) after primary surgical treatment and l can be used to plan an individual surveillance strategy based on prognostic factors.
This tool will help you find out your relative risk for cervical cancer. This tool is valid for women between the ages of 21 and 69 who have had sexual intercourse at least once and who have not had a hysterectomy with removal of the cervix.
CERVICAL CANCER - GUIDELINES Despite significant advances in the screening, detection and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management and mortality of cervical cancer1.
